Saturday 17 October 2026
Export AVR’s income statement to Excel — free account
Anteris Technologies Global Corp.
AVR Healthcare Medical Instruments & Supplies
Anteris Technologies Global Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 million, down 29.2% from fiscal 2024. In the quarter to June 2026, revenue grew 63.3%, EPS grew 48.3%, free cash flow fell 6.84% and total debt rose 8.15%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
6.05
0.31
−4.87%
Follow AVR
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+7 more TTM periods Free account |
(757.94%) | (301.60%) | (59.28%) | (75.13%) | |
| (340.10%) | (181.58%) | (53.92%) | (66.31%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(2,731.44%) | 21,592.66% | (34.26%) | (41.77%) | |
Average Days of Receivables |
39.93 | 6.11 | 45.55 | 89.22 | |
Free Cash Flow per Share |
(2.20) | (2.16) | (1.05) | (0.91) | |
Free Cash Flow |
(79.43) | (79.76) | (86.84) | (88.27) | |
Capital Expenditures |
(1.92) | (1.95) | (1.84) | (2.01) | |
| Other line items | |||||
Cash ROIC |
(630.43%) | (645.23%) | (15.44%) | (17.32%) | |
Accounts Receivable Turnover |
6.66 | 15.94 | 8.81 | 3.63 | |
Accounts Payable Turnover |
0.19 | 0.07 | 0.10 | 0.11 | |
Inventory Turnover |
1.56 | 1.71 | 1.96 | 2.46 | |
Average Days of Payables |
2,271.82 | 7,116.54 | 2,906.20 | 3,317.53 | |
Days of Inventory on Hand |
231.64 | 97.50 | 93.55 | 5.21 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
2,941.61% | 3,613.17% | 3,788.28% | 3,441.12% | |
Selling, General and Administrative Expense of Revenue |
1,167.79% | 1,365.29% | 1,478.93% | 1,372.21% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
(1,217.58) | (1,286.22) | (1,298.93) | (580.51) | |
Operating CF/Net income |
0.92 | 0.83 | 0.89 | 0.83 | |
Depreciation/Fixed assets |
0.31 | 0.32 | 0.33 | 0.31 | |
Capex/Depreciation |
(1.17) | (1.18) | (1.09) | (1.16) | |
Revenue per Share |
0.06 | 0.05 | 0.02 | 0.02 | |
Operating CF per Share |
(2.15) | (2.11) | (1.02) | (0.89) | |
Capex per Share |
(0.05) | (0.05) | (0.02) | (0.02) | |
Capex to Sales |
0.90 | 1.02 | 1.00 | 0.90 |
Columns are period end dates